We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Fed. Circ. Pushed To Ax Merck Antifungal Infringement Ruling

Law360, Washington (March 7, 2016, 6:31 PM EST) -- Xellia asked a Federal Circuit panel Monday to reverse a lower court’s ruling that the company's generic version of anti-fungal medication Cancidas infringed Merck’s patent, arguing the patent called for a...
To view the full article, register now.

Related

Sections

Case Information

Case Title

Subscribers Only

Case Number

Subscribers Only

Court

Appellate - Federal Circuit

Nature of Suit

830 Patent Infringement (Fed. Question)

Date Filed

August 5, 2015

Law Firms

Companies

Government Agencies

Patents

Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.